{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T10:30:45Z","timestamp":1774434645162,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T00:00:00Z","timestamp":1548892800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["surg case rep"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1186\/s40792-019-0573-1","type":"journal-article","created":{"date-parts":[[2019,1,31]],"date-time":"2019-01-31T09:03:48Z","timestamp":1548925428000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Bevacizumab is associated with delayed anastomotic leak after low anterior resection with preoperative radiotherapy for rectal cancer: a case report"],"prefix":"10.1186","volume":"5","author":[{"given":"Erika","family":"Machida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4464-2465","authenticated-orcid":false,"given":"Yasuyuki","family":"Miyakura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sawako","family":"Tamaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hideki","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumi","family":"Hasegawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rina","family":"Kikugawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shingo","family":"Tsujinaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan Kawarai","family":"Lefor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiki","family":"Rikiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,1,31]]},"reference":[{"issue":"16","key":"573_CR1","doi-asserted-by":"publisher","first-page":"3697","DOI":"10.1200\/JCO.2005.05.112","volume":"23","author":"FF Kabbinavar","year":"2005","unstructured":"Kabbinavar FF, Schulz J, McCleod M, Patel T, Hamm JT, Hecht JR, et al. Addition of bevacizumab to bolus fluorouracil and leucovorin in first-line metastatic colorectal cancer: results of a randomized phase II trial. J Clin Oncol. 2005;23(16):3697\u2013705.","journal-title":"J Clin Oncol"},{"issue":"3","key":"573_CR2","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1634\/theoncologist.12-3-356","volume":"12","author":"MH Cohen","year":"2007","unstructured":"Cohen MH, Gootenberg J, Keegan P, Pazdur R. FDA drug approval summary: bevacizumab plus FOLFOX4 as second-line treatment of colorectal cancer. Oncologist. 2007;12(3):356\u201361.","journal-title":"Oncologist"},{"issue":"6","key":"573_CR3","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1093\/annonc\/mdq587","volume":"22","author":"FA Schutz","year":"2011","unstructured":"Schutz FA, Je Y, Azzi GR, Nguyen PL, Choueiri TK. Bevacizumab increases the risk of arterial ischemia: a large study in cancer patients with a focus on different subgroup outcomes. Ann Oncol. 2011;22(6):1404\u201312.","journal-title":"Ann Oncol"},{"issue":"1\u20132","key":"573_CR4","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1159\/000314980","volume":"79","author":"S Hapani","year":"2010","unstructured":"Hapani S, Sher A, Chu D, Wu S. Increased risk of serious hemorrhage with bevacizumab in cancer patients: a meta-analysis. Oncology. 2010;79(1\u20132):27\u201338.","journal-title":"Oncology"},{"issue":"6","key":"573_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/S1470-2045(09)70112-3","volume":"10","author":"S Hapani","year":"2009","unstructured":"Hapani S, Chu D, Wu S. Risk of gastrointestinal perforation in patients with cancer treated with bevacizumab: a meta-analysis. Lancet Oncol. 2009;10(6):559\u201368.","journal-title":"Lancet Oncol"},{"issue":"2","key":"573_CR6","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/jso.20938","volume":"97","author":"DA August","year":"2008","unstructured":"August DA, Serrano D, Poplin EB. Spontaneous delayed colon and rectal anastomotic complications associated with bevacizumab therapy. J Surg Oncol. 2008;97(2):180\u20135.","journal-title":"J Surg Oncol"},{"issue":"6","key":"573_CR7","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1007\/s10350-007-0231-8","volume":"50","author":"EJ Ley","year":"2007","unstructured":"Ley EJ, Vukasin P, Kaiser AM, Ault G, Beart RW Jr. Delayed rectovaginal fistula: a potential complication of bevacizumab (Avastin). Dis Colon Rectum. 2007;50(6):930.","journal-title":"Dis Colon Rectum"},{"issue":"4","key":"573_CR8","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1245\/s10434-008-0279-2","volume":"16","author":"T Bege","year":"2009","unstructured":"Bege T, Lelong B, Viret F, Turrini O, Guiramand J, Topart D, et al. Bevacizumab-related surgical site complication despite primary tumor resection in colorectal cancer patients. Ann Surg Oncol. 2009;16(4):856\u201360.","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"573_CR9","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/gut.2006.112524","volume":"56","author":"A Adenis","year":"2007","unstructured":"Adenis A, Vanseymortier L, Foissey D, Colombel JF. Bevacizumab and postponed suture leakages after surgery for ulcerative colitis and rectal cancer. Gut. 2007;56(5):734.","journal-title":"Gut"},{"issue":"2","key":"573_CR10","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s13304-013-0207-2","volume":"65","author":"D Borzomati","year":"2013","unstructured":"Borzomati D, Nappo G, Valeri S, Vincenzi B, Ripetti V, Coppola R. Infusion of bevacizumab increases the risk of intestinal perforation: results on a series of 143 patients consecutively treated. Updat Surg. 2013;65(2):121\u20134.","journal-title":"Updat Surg"},{"issue":"2","key":"573_CR11","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1007\/s11845-017-1676-y","volume":"187","author":"T O'Hare","year":"2018","unstructured":"O'Hare T, McDermott R, Hannon R. Late anastomotic breakdown with bevacizumab in colorectal cancers, a case-based review. Ir J Med Sci. 2018;187(2):333\u20136.","journal-title":"Ir J Med Sci"},{"issue":"2","key":"573_CR12","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jamcollsurg.2008.10.015","volume":"208","author":"TP Kingham","year":"2009","unstructured":"Kingham TP, Pachter HL. Colonic anastomotic leak: risk factors, diagnosis, and treatment. J Am Coll Surg. 2009;208(2):269\u201378.","journal-title":"J Am Coll Surg"},{"issue":"12","key":"573_CR13","doi-asserted-by":"publisher","first-page":"3608","DOI":"10.1007\/s00464-015-4117-x","volume":"29","author":"H Qu","year":"2015","unstructured":"Qu H, Liu Y, Bi DS. Clinical risk factors for anastomotic leakage after laparoscopic anterior resection for rectal cancer: a systematic review and meta-analysis. Surg Endosc. 2015;29(12):3608\u201317.","journal-title":"Surg Endosc"},{"issue":"25","key":"573_CR14","doi-asserted-by":"publisher","first-page":"5718","DOI":"10.3748\/wjg.v22.i25.5718","volume":"22","author":"K Kawada","year":"2016","unstructured":"Kawada K, Sakai Y. Preoperative, intraoperative and postoperative risk factors for anastomotic leakage after laparoscopic low anterior resection with double stapling technique anastomosis. World J Gastroenterol. 2016;22(25):5718\u201327.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"573_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1007\/s00384-010-0938-1","volume":"25","author":"US Shin","year":"2010","unstructured":"Shin US, Kim CW, Yu CS, Kim JC. Delayed anastomotic leakage following sphincter-preserving surgery for rectal cancer. Int J Color Dis. 2010;25(9):843\u20139.","journal-title":"Int J Color Dis"},{"issue":"4","key":"573_CR16","doi-asserted-by":"publisher","first-page":"O135","DOI":"10.1111\/codi.13300","volume":"18","author":"SB Lim","year":"2016","unstructured":"Lim SB, Yu CS, Kim CW, Yoon YS, Park IJ, Kim JC. Late anastomotic leakage after low anterior resection in rectal cancer patients: clinical characteristics and predisposing factors. Color Dis. 2016;18(4):O135\u201340.","journal-title":"Color Dis"},{"issue":"2","key":"573_CR17","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0167-8140(96)01880-4","volume":"42","author":"MK Tibbs","year":"1997","unstructured":"Tibbs MK. Wound healing following radiation therapy: a review. Radiother Oncol. 1997;42(2):99\u2013106.","journal-title":"Radiother Oncol"},{"key":"573_CR18","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1186\/s12885-016-2734-y","volume":"16","author":"TEA Botrel","year":"2016","unstructured":"Botrel TEA, Clark LGO, Paladini L, Clark OAC. Efficacy and safety of bevacizumab plus chemotherapy compared to chemotherapy alone in previously untreated advanced or metastatic colorectal cancer: a systematic review and meta-analysis. BMC Cancer. 2016;16:677.","journal-title":"BMC Cancer"},{"issue":"9","key":"573_CR19","doi-asserted-by":"publisher","first-page":"862","DOI":"10.1634\/theoncologist.2009-0071","volume":"14","author":"M Kozloff","year":"2009","unstructured":"Kozloff M, Yood MU, Berlin J, Flynn PJ, Kabbinavar FF, Purdie DM, et al. Clinical outcomes associated with bevacizumab-containing treatment of metastatic colorectal cancer: the BRiTE observational cohort study. Oncologist. 2009;14(9):862\u201370.","journal-title":"Oncologist"},{"issue":"3","key":"573_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/jjco\/hyv182","volume":"46","author":"K Hatake","year":"2016","unstructured":"Hatake K, Doi T, Uetake H, Takahashi Y, Ishihara Y, Shirao K. Bevacizumab safety in Japanese patients with colorectal cancer. Jpn J Clin Oncol. 2016;46(3):234\u201340.","journal-title":"Jpn J Clin Oncol"},{"issue":"13","key":"573_CR21","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1056\/NEJM200009283431302","volume":"343","author":"LB Saltz","year":"2000","unstructured":"Saltz LB, Cox JV, Blanke C, Rosen LS, Fehrenbacher L, Moore MJ, et al. Irinotecan plus fluorouracil and leucovorin for metastatic colorectal cancer. Irinotecan Study Group. N Engl J Med. 2000;343(13):905\u201314.","journal-title":"N Engl J Med"},{"issue":"10","key":"573_CR22","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1007\/s40262-018-0644-7","volume":"57","author":"FM Man de","year":"2018","unstructured":"de Man FM, Goey AKL, van Schaik RHN, Mathijssen RHJ, Bins S. Individualization of irinotecan treatment: a review of pharmacokinetics, pharmacodynamics, and pharmacogenetics. Clin Pharmacokinet. 2018;57(10):1229\u201354.","journal-title":"Clin Pharmacokinet"},{"issue":"9","key":"573_CR23","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1046\/j.1365-2168.1999.01223.x","volume":"86","author":"JM Hendriks","year":"1999","unstructured":"Hendriks JM, Hubens G, Wuyts FL, Vermeulen P, Hubens A, Eyskens E. Experimental study of intraperitoneal suramin on the healing of colonic anastomoses. Br J Surg. 1999;86(9):1171\u20135.","journal-title":"Br J Surg"},{"issue":"3","key":"573_CR24","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1245\/aso.2002.9.3.303","volume":"9","author":"EA Velde te","year":"2002","unstructured":"te Velde EA, Voest EE, van Gorp JM, Verheem A, Hagendoorn J, Gebbink MF, et al. Adverse effects of the antiangiogenic agent angiostatin on the healing of experimental colonic anastomoses. Ann Surg Oncol. 2002;9(3):303\u20139.","journal-title":"Ann Surg Oncol"}],"container-title":["Surgical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-019-0573-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s40792-019-0573-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s40792-019-0573-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,1,30]],"date-time":"2020-01-30T19:07:54Z","timestamp":1580411274000},"score":1,"resource":{"primary":{"URL":"https:\/\/surgicalcasereports.springeropen.com\/articles\/10.1186\/s40792-019-0573-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,31]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["573"],"URL":"https:\/\/doi.org\/10.1186\/s40792-019-0573-1","relation":{},"ISSN":["2198-7793"],"issn-type":[{"value":"2198-7793","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,31]]},"assertion":[{"value":"28 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 January 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The institutional ethics committee determined that approval was not necessary for a case report. However, patient anonymity has been preserved and personal information has been protected. Informed consent was obtained from the patient.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written consent for the publication of this case report with accompanying images was obtained from the patient.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Publisher\u2019s Note"}}],"article-number":"14"}}